The Biden Administration Drops Its Foolish Resistance to Drug-Price Transparency

Now Congress should empower Americans with the truth about health-care prices, without exception.

Share this story

A pharmacist fills a prescription at a pharmacy in New York City, 2009.

Lucas Jackson/Reuters

Americans finally have some good news on health care. After years of skyrocketing costs, lower prescription drug prices are coming — despite President Biden’s efforts to force Americans to keep paying more.

That’s a victory our organization won last week in federal court. Earlier this year, we sued the Biden administration for its refusal to implement price transparency for prescription drugs. In 2020, the Trump administration finalized a regulation requiring group health plans and many health-insurance issuers to disclose the price of prescription drugs to consumers.

TB

About the Author

Tarren Bragdon

Tarren Bragdon is the president and CEO of the Foundation for Government Accountability.

SW

About the Author

Stewart Whitson

Stewart Whitson is legal director of the Foundation for Government Accountability.

Comments

Advertisement

Advertisement